PET/CT in the evaluation of the treatment response in lymphomas; [Lenfomalarda tedavi yanıtının değerlendirilmesinde PET/BT]

Simple item page
dc.contributor.authorMütevelizade G.Y.
dc.date.accessioned2024-07-22T08:06:29Z
dc.date.available2024-07-22T08:06:29Z
dc.date.issued2021
dc.description.abstractThe Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is a functional and metabolic imaging modality with high sensitivity and accuracy for staging, restaging, and evaluation of response to treatment in Non-Hodgkin and Hodgkin lymphoma patients. Objective and accurate evaluation of treatment response in interim (iPET) and end of treatment (ePET) PET/CT is one of the most important parameters of patient management. In this review, standardization studies used in the evaluation of treatment response with PET/CT in lymphomas, the importance of iPET and ePET in patient management, metabolic tumor markers and pitfalls that can be followed in PET/CT after treatment were evaluated. © 2021 Nuclear Medicine Seminars. All rights reserved.
dc.identifier.DOI-ID10.4274/NTS.GALENOS.2021.0017
dc.identifier.issn21496447
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13556
dc.language.isoTurkish
dc.publisherGalenos Publishing House
dc.rightsAll Open Access; Bronze Open Access
dc.subjecttumor marker
dc.subjectcancer therapy
dc.subjecthuman
dc.subjectlymphoma
dc.subjectpositron emission tomography-computed tomography
dc.subjectReview
dc.subjectstandardization
dc.subjecttreatment response
dc.titlePET/CT in the evaluation of the treatment response in lymphomas; [Lenfomalarda tedavi yanıtının değerlendirilmesinde PET/BT]
dc.typeReview

Files

Collections

Scopus Koleksiyonu